These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21807936)

  • 1. PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer.
    Johnson EO; Chang KH; de Pablo Y; Ghosh S; Mehta R; Badve S; Shah K
    J Cell Sci; 2011 Aug; 124(Pt 16):2711-22. PubMed ID: 21807936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy.
    Johnson EO; Chang KH; Ghosh S; Venkatesh C; Giger K; Low PS; Shah K
    J Cell Sci; 2012 Mar; 125(Pt 5):1204-16. PubMed ID: 22492986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
    Nagai MA; Fregnani JH; Netto MM; Brentani MM; Soares FA
    Breast Cancer Res Treat; 2007 Nov; 106(1):49-56. PubMed ID: 17211533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of the PHLDA1 gene in IMR-32 neuroblastoma cells increases levels of Aurora A, TRKB and affects proteins involved in apoptosis and autophagy pathways.
    Durbas M; Horwacik I; Boratyn E; Rokita H
    Int J Oncol; 2016 Aug; 49(2):823-37. PubMed ID: 27278006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional cyclin D1 overexpression or hypoxia correlate inversely with heterogeneous oestrogen receptor-alpha expression in human breast cancer.
    Kronblad A; Helczynska K; Nielsen NH; Påhlman E; Emdin S; Påhlman S; Landberg G
    In Vivo; 2003; 17(4):311-8. PubMed ID: 12929585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres.
    Kastrati I; Canestrari E; Frasor J
    Oncogene; 2015 Apr; 34(18):2309-16. PubMed ID: 24954507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line.
    Wang XX; Liu R; Jin SQ; Fan FY; Zhan QM
    Cell Res; 2006 Apr; 16(4):356-66. PubMed ID: 16617331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aurora-A kinase phosphorylation of Aurora-A kinase interacting protein (AIP) and stabilization of the enzyme-substrate complex.
    Katayama H; Sasai K; Czerniak BA; Carter JL; Sen S
    J Cell Biochem; 2007 Dec; 102(5):1318-31. PubMed ID: 17957726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential susceptibility to hydrogen sulfide-induced apoptosis between PHLDA1-overexpressing oral cancer cell lines and oral keratinocytes: role of PHLDA1 as an apoptosis suppressor.
    Murata T; Sato T; Kamoda T; Moriyama H; Kumazawa Y; Hanada N
    Exp Cell Res; 2014 Jan; 320(2):247-57. PubMed ID: 24270013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma.
    Kurai M; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Suzuki A; Konishi I
    Hum Pathol; 2005 Dec; 36(12):1281-8. PubMed ID: 16311121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
    Park SS; Kim SW
    Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-molecule inhibition of Aurora kinases triggers spindle checkpoint-independent apoptosis in cancer cells.
    Sun L; Li D; Dong X; Yu H; Dong JT; Zhang C; Lu X; Zhou J
    Biochem Pharmacol; 2008 Mar; 75(5):1027-34. PubMed ID: 18163976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EWS-Fli1 up-regulates expression of the Aurora A and Aurora B kinases.
    Wakahara K; Ohno T; Kimura M; Masuda T; Nozawa S; Dohjima T; Yamamoto T; Nagano A; Kawai G; Matsuhashi A; Saitoh M; Takigami I; Okano Y; Shimizu K
    Mol Cancer Res; 2008 Dec; 6(12):1937-45. PubMed ID: 19074838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype.
    Baba F; Swartz K; van Buren R; Eickhoff J; Zhang Y; Wolberg W; Friedl A
    Breast Cancer Res Treat; 2006 Jul; 98(1):91-8. PubMed ID: 16636895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aurora-A interacts with Cyclin B1 and enhances its stability.
    Qin L; Tong T; Song Y; Xue L; Fan F; Zhan Q
    Cancer Lett; 2009 Mar; 275(1):77-85. PubMed ID: 19028417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells.
    Bonatto N; Carlini MJ; de Bessa Garcia SA; Nagai MA
    Cell Adh Migr; 2018 Jan; 12(1):37-46. PubMed ID: 28640659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic role of nuclear accumulated Aurora-A.
    Tatsuka M; Sato S; Kanda A; Miki T; Kamata N; Kitajima S; Kudo Y; Takata T
    Mol Carcinog; 2009 Sep; 48(9):810-20. PubMed ID: 19204928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation.
    Neef R; Kuske MA; Pröls E; Johnson JP
    Cancer Res; 2002 Oct; 62(20):5920-9. PubMed ID: 12384558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
    Macaluso M; Cinti C; Russo G; Russo A; Giordano A
    Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Node negative breast carcinoma: hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators.
    Patel DD; Bhatavdekar JM; Chikhlikar PR; Ghosh N; Suthar TP; Shah NG; Mehta RH; Balar DB
    J Surg Oncol; 1996 Jun; 62(2):86-92. PubMed ID: 8649046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.